U.S. Food and Drug Administration

FDA Approves Groundbreaking Rapid-Acting Insulin Biosimilar Merilog, Offering New Hope for Millions Battling Diabetes

WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) recently approved Merilog (insulin-aspart-szjj) as the first rapid-acting insulin biosimilar to Novolog (insulin aspart). This new treatment option, aimed at …

FDA Approves Groundbreaking Rapid-Acting Insulin Biosimilar Merilog, Offering New Hope for Millions Battling Diabetes Read More

U.S. Food and Drug Administration

FDA Approves First Generic Liraglutide Injection, Ushering in a New Era for Type 2 Diabetes Treatment

WASHINGTON, D.C. — The fight against type 2 diabetes just reached a groundbreaking milestone. Last week, the U.S. Food and Drug Administration (FDA) approved the first generic version of liraglutide injection, …

FDA Approves First Generic Liraglutide Injection, Ushering in a New Era for Type 2 Diabetes Treatment Read More